Aarti Drugs Limited's market cap is currently ₹46.15B. The company's EPS TTM is ₹5.9; its P/E ratio is 24.45; and it has a dividend yield of 0.20%. Aarti Drugs Limited is scheduled to report earnings on July 18, 2025, and the estimated EPS forecast is ₹4.90. See an overview of income statement, balance sheet, and cash flow financials.
